Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
106M
-
Number of holders
-
184
-
Total 13F shares, excl. options
-
53.2M
-
Shares change
-
+1.33M
-
Total reported value, excl. options
-
$814M
-
Value change
-
+$20.4M
-
Put/Call ratio
-
0.6
-
Number of buys
-
85
-
Number of sells
-
-96
-
Price
-
$15.29
Significant Holders of Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) as of Q3 2024
221 filings reported holding RCUS - Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) has 184 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.2M shares
of 106M outstanding shares and own 50.39% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (9.73M shares), VANGUARD GROUP INC (5.47M shares), FMR LLC (4.47M shares), Woodline Partners LP (3.48M shares), STATE STREET CORP (3.01M shares), Point72 Asset Management, L.P. (2.44M shares), Siren, L.L.C. (1.61M shares), Boxer Capital, LLC (1.6M shares), DIMENSIONAL FUND ADVISORS LP (1.52M shares), and AMERIPRISE FINANCIAL INC (1.32M shares).
This table shows the top 184 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.